These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 6235712)
1. Releasing effect of thymidine on G1 phase arrest of erythroleukemia cells caused by FUDR and HMBA. Bin X; DiLiberto M; Rifkind RA; Marks PA Zhongguo Yao Li Xue Bao; 1984 Jun; 5(2):133-7. PubMed ID: 6235712 [No Abstract] [Full Text] [Related]
2. Antagonistic effect of butyrate on hexamethylene bisacetamide induced differentiation of murine erythroleukemia cells. Corin RE; Haspel HC; Peretz AM; Sonenberg M; Rifkind RA Cancer Res; 1986 Mar; 46(3):1136-41. PubMed ID: 3455880 [TBL] [Abstract][Full Text] [Related]
3. Depletion of sodium butyrate from the culture medium of Friend erythroleukemia cells undergoing differentiation. Friend C; Zajac-Kaye M; Holland JG; Pogo BG Cancer Res; 1987 Jan; 47(2):378-82. PubMed ID: 3466690 [TBL] [Abstract][Full Text] [Related]
4. Seric factors influence cell cycle modifications during commitment of murine erythroleukemia cells to differentiation. Mencherini F; Khochbin S; Chabanas A; Lawrence JJ Cytometry; 1992; 13(5):518-24. PubMed ID: 1633731 [TBL] [Abstract][Full Text] [Related]
5. In vitro studies on the mechanism of tumor promoter-mediated inhibition of cell differentiation. Yamasaki H; Drevon C; Martel N Carcinog Compr Surv; 1982; 7():359-77. PubMed ID: 7039831 [No Abstract] [Full Text] [Related]
6. Iron-responsive element-binding protein mRNA levels during erythroid differentiation of murine erythroleukemia cells. Fuchs O Neoplasma; 1995; 42(4):179-85. PubMed ID: 7659183 [TBL] [Abstract][Full Text] [Related]
7. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity. Murate T; Yamashita K; Ohashi H; Kagami Y; Tsushita K; Kinoshita T; Hotta T; Saito H; Yoshida S; Mori KJ Exp Hematol; 1993 Jan; 21(1):169-76. PubMed ID: 8417953 [TBL] [Abstract][Full Text] [Related]
15. Demonstration of commitment by K562 human erythroleukemia cells. Rowley PT; Ohlsson-Wilhelm BM Prog Clin Biol Res; 1985; 191():217-31. PubMed ID: 3863148 [TBL] [Abstract][Full Text] [Related]
16. Growth and intestinal differentiation are independently regulated in HT29 colon cancer cells. Schroy PC; Rustgi AK; Ikonomu E; Liu XP; Polito J; Andry C; O'Keane JC J Cell Physiol; 1994 Oct; 161(1):111-23. PubMed ID: 7929596 [TBL] [Abstract][Full Text] [Related]
17. Potentiation of retinoic acid-induced differentiation of human acute promyelocytic leukemia NB4 cells by butyric acid, tributyrin, and hexamethylene bisacetamide. Taimi M; Chen ZX; Breitman TR Oncol Res; 1998; 10(2):75-84. PubMed ID: 9666515 [TBL] [Abstract][Full Text] [Related]
18. Transfected wild-type and mutant max regulate cell growth and differentiation of murine erythroleukemia cells. Cogliati T; Dunn BK; Bar-Ner M; Cultraro CM; Segal S Oncogene; 1993 May; 8(5):1263-8. PubMed ID: 8479748 [TBL] [Abstract][Full Text] [Related]
19. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression. Suhasini M; Boss GR; Pascual FE; Pilz RB Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161 [TBL] [Abstract][Full Text] [Related]
20. Bcl-XL induction during terminal differentiation of friend erythroleukaemia cells correlates with delay of apoptosis and loss of proliferative capacity but not with haemoglobinization. Hafid-Medheb K; Poindessous-Jazat V; Augery-Bourget Y; Hanania N; Robert-Lézénès J Cell Death Differ; 1999 Feb; 6(2):166-74. PubMed ID: 10200563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]